Glutamine, an amino acid, is synthesized in brain tissue from ammonia and alpha-ketoglutarate. Production of glutamine, the most prominent amino acid in CSF, provides a mechanism for removing the ammonia, a toxic metabolic waste product, from the CNS.
The determination of CSF glutamine level provides an indirect test for the presence of excess ammonia in the CSF. As the concentration of ammonia in the CSF increases, the supply of alpha-ketoglutarate becomes depleted; consequently, glutamine can no longer be produced to remove the toxic ammonia, and coma ensues. A CSF glutamine test is therefore frequently requested for patients with coma of unknown origin.
8.6 ± 0.50 mg/dL or 0.60 ± 0.03 mmol/L or 590 ± 34 μmol/L
Clinical Alert
A CSF glutamine value >35 mg/dL (>2.4 mmol/L) usually results in loss of consciousness
A lumbar puncture is performed (see Lumbar Puncture [Spinal Tap]).
Use 1 mL of CSF for the glutamine test in a sterile screw-top tube.
Centrifuge the samples if cells are present.
Increased CSF glutamine levels are associated with the following conditions:
Hepatic encephalopathy (glutamine values >35 mg/dL or >2.4 mmol/L are diagnostic)
Reye syndrome (typically affects the brain and liver of children after a viral infection)
Encephalopathy secondary to hypercapnia or sepsis
Bacterial meningitis
Pretest Patient Care
Follow pretest patient care for lumbar puncture (see Lumbar Puncture [Spinal Tap]).
Follow guidelines in Chapter 1 for safe, effective, informed pretest care.
Posttest Patient Care
Review abnormal glutamine levels; report and record findings. Modify the nursing care plan as needed to prevent complications. Correlate with clinical symptoms.
Follow posttest patient care for lumbar puncture (see Lumbar Puncture [Spinal Tap]).
Follow guidelines in Chapter 1 for safe, effective, informed posttest care.